BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · Real-Time Price · USD
1.970
-0.030 (-1.50%)
At close: Jul 11, 2025, 4:00 PM
2.060
+0.090 (4.57%)
After-hours: Jul 11, 2025, 7:33 PM EDT
BioXcel Therapeutics Market Cap
BioXcel Therapeutics has a market cap or net worth of $11.93 million as of July 11, 2025. Its market cap has decreased by -73.06% in one year.
Market Cap
11.93M
Enterprise Value
86.79M
1-Year Change
-73.06%
Ranking
Category
Stock Price
$1.97
Market Cap Chart
Since March 8, 2018, BioXcel Therapeutics's market cap has decreased from $172.57M to $11.93M, a decrease of -93.09%. That is a compound annual growth rate of -30.48%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 702.36B |
| Johnson & Johnson | 377.32B |
| AbbVie | 339.75B |
| Novo Nordisk | 316.64B |
| UnitedHealth Group | 273.96B |
| Novartis AG | 243.81B |
| Abbott Laboratories | 229.45B |
| AstraZeneca | 223.49B |